[COMPARATIVE STUDY OF IMMUNOGENICITY AND PROTECTIVE EFFECT OF LIVE COLD-ADAPTED AND INACTIVATED VACCINES AGAINST TYPE A INFLUENZA]
- PMID: 26259268
[COMPARATIVE STUDY OF IMMUNOGENICITY AND PROTECTIVE EFFECT OF LIVE COLD-ADAPTED AND INACTIVATED VACCINES AGAINST TYPE A INFLUENZA]
Abstract
Aim: Direct comparative studies of immunogenicity and protective effect of live cold-adapted (ca) and inactivated vaccines against type A influenza.
Materials and methods: Groups of mice were immunized intramuscularly (i/m) or intranasally (i/n) twice with inactivated or live ca vaccines based on wild-type parent strain A/Krasnodar/101/59 (H2N2) and the corresponding ca donor strain A/Krasnodar/101/59/30CE/5MDCK/l/7/4 (H2N2), respectively. Immunogenicity was determined by HAI antibodies in sera and lungs (extracts) against both vaccine strains. Protective effect--by the level of wild-type strain in lungs of immunized mice after the infection.
Results: Live ca and inactivated vaccines based on similar strains increase immunogenicity and protective effect when administered via different routes in varying patterns. A significant increase of immunogenicity was only observed for i/m (sera antibodies) and i/n (lung antibodies) administration of the live ca vaccine, and could be determined by antigenic features of the vaccine strains. At the same time, all the vaccine variants and administration routes induced at least partial protection from infection compared with unimmunized control. However, complete protection from infection was only noted for the i/m administered live ca vaccine.
Conclusion: A combination of immunization variant and vaccine type determines immunogenicity and protective effect, and their interconnection requires further studies using all the possible combinations of preparations and administration routes as well as determination of induction of various components of the immune system.
Similar articles
-
[COLD-ADAPTED A/KRASNODAR/101/35/59 (H2N2) STRAIN--A PROMISING STRAIN-DONOR OF ATTENUATION FOR PROCURATION OF LIVE INFLUENZA VACCINES].Zh Mikrobiol Epidemiol Immunobiol. 2015 Sep-Oct;(5):27-32. Zh Mikrobiol Epidemiol Immunobiol. 2015. PMID: 26829850 Russian.
-
[Increase of immunogenicity of cold-adapted influenza vaccine by using adjuvant].Zh Mikrobiol Epidemiol Immunobiol. 2010 Sep-Oct;(5):29-34. Zh Mikrobiol Epidemiol Immunobiol. 2010. PMID: 21061574 Russian.
-
Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.Vaccine. 2006 Mar 10;24(11):1966-74. doi: 10.1016/j.vaccine.2005.10.051. Epub 2005 Nov 8. Vaccine. 2006. PMID: 16343703
-
[Live attenuated and inactivated influenza vaccines: data from direct comparative studies].Zh Mikrobiol Epidemiol Immunobiol. 2014 Jan-Feb;(1):103-19. Zh Mikrobiol Epidemiol Immunobiol. 2014. PMID: 24738303 Review. Russian.
-
Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.Drugs R D. 2003;4(5):312-9. doi: 10.2165/00126839-200304050-00007. Drugs R D. 2003. PMID: 12952502 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical